Alai Goñi Ramirez, radiation oncologist at Onkologikoa, shared a post on LinkedIn:
“Delighted to share that our collaborative work with Naru Intelligence ’20 years of HDR brachytherapy boost in high-risk prostate cancer patients: long-term outcomes’ has been selected as a Proffered Paper at Estro meets Asia congress 2024.
Thank you, Macarena Sevilla Ayensa, and to your entire team!
See you in Kuala Lumpur! ”
Source: Alai Goñi Ramirez/LinkedIn